Early diagnostic of B cell chronic leukemia by novel biomarkers
Manuel Fuentes, Raquel Bartolomé-Casado, María González‐González, Fridtjof Lund‐Johansen, Alberto Órfão
Abstract
Open-access reader
Manuel Fuentes, Raquel Bartolomé-Casado, María González‐González, Fridtjof Lund‐Johansen, Alberto Órfão
Abstract
Open-access reader
B-cell chronic lymphocytic leukemia (B-CLL) is the most common type of leukemias. Normally, CLL is a disease of adults, but in most cases, it can occur in teenagers and occasionally in children (inherited). Most of the people are diagnosed without symptoms as the result of a routine blood test that returns a high white blood cell count. CLL is first suspected by the presence of lymphocytosis; however, it is increasing the number of adults with an increment of aberrant B cells populations before a lymphocytosis appears.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
B-cell chronic lymphocytic leukemia (B-CLL) is the most common type of leukemias. Normally, CLL is a disease of adults, but in most cases, it can occur in teenagers and occasionally in children (inherited). Most of the people are diagnosed without symptoms as the result of a routine blood test that returns a high white blood cell count. CLL is first suspected by the presence of lymphocytosis; however, it is increasing the number of adults with an increment of aberrant B cells populations before a lymphocytosis appears.
Key concepts: Lymphocytosis, Chronic lymphocytic leukemia, Medicine, Leukemia, Immunology, White blood cell, Disease, Pathology